You are here

Home » Content

Birinci basamakta diyabetes mellitusa yaklaşım

Approach to diabetes mellitus in primary care

Journal Name:

  • Smyrna Tıp Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Diabetes mellitus is caused by a defect on insulin secretion, insulin action or both of these factors. It is a chronic metabolic disorder that characterized by hyperglycemia; organism can not sufficiently benefit from carbohydrate, fat and protein in this disease. If diabetes can not be controlled; acute and chronic complications occur and adverse effects can cause serious morbidity and mortality. To reduce morbidity and mortality in diabetes, information and education awareness of health professionals and patients, must be increased. With this aim, issue of diabetes mellitus in primary care was reviewed in this article.
Bookmark/Search this post with
Abstract (Original Language): 
Diyabetes mellitus; insülin sekresyonunda, insülin etkisinde veya bu faktörlerin her ikisinde de bir bozukluk olması sonucu ortaya çıkar. Hiperglisemiyle karakterize olan, organizmanın karbonhidrat, yağ ve proteinlerden yeterince yararlanamadığı, kronik ve metabolik bir hastalıktır. Diyabet, kontrol sağlanamadığında akut ve kronik komplikasyonlara yol açıp morbidite ve mortaliteyi ciddi anlamda olumsuz etkiler. Diyabette morbidite ve mortaliteyi azaltmak için sağlık çalışanlarının ve hastaların, eğitimle bilgi ve bilinç düzeylerinin artırılması gerekir. Makalede bu amaçla birinci basamak sağlık hizmetlerinde diyabete yaklaşım konusu gözden geçirilmiştir.
FULL TEXT (PDF): 
PDF icon arastirmax-birinci-basamakta-diyabetes-mellitusa-yaklasim.pdf
  • 1
54-61
  • Turkish

REFERENCES

References: 

1. Ferranini E. Insulin resistance versus insulin
deficiency in noninsulin dependent diabetes
mellitus: Problems and prospects. Endocr Rev 1998;
19:447-448.
2. Narayan KM, Boyle JP. Lifetime risk for diabetes
mellitus in united states. JAMA 2003;
290(14):1884-1890.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates
of the prevalence of diabetes for 2010 and 2030.
Diabetes Research and Clinical Practice 2010;
87(1):4-14.
4. Satman İ ve TURDEP-II Çalışma Grubu. TURDEPII
Çalışması ilk sonuçlar, 32.TEMH Kongresi, 13-
17 Ekim 2010, Antalya.
5. Hogan P, Dall T, Nikolov P. American Diabetes
Association. Economic costs of diabetes in the US
in 2002. Diabetes Care 2003; 26(3):917-932.
6. American Diabetes Association. Standards of
Medical Care in Diabetes-2012. Diabetes Care
2012; 35(1):11-63.
7. Nguyen TT, Wang JJ, Wong TY. Retinal vascular
changes in pre-diabetes and prehypertension: new
findings and their research and clinical implications.
Diabetes Care 2007; 30(10):2708-2715.
8. American Diabetes Association. Diagnosis and
classification of diabetes mellitus. Diabetes Care
2010; 33(1):62-69.
9. TEMD Diabetes Mellitus Çalışma ve Eğitim Grubu.
TEMD Diabetes Mellitus ve Komplikasyonlarının
tanı, tedavi ve izlem Klavuzu-2011, 5. Baskı, Miki
Matbaacılık San ve Tic. Ltd. Şti.. Ankara, 2011.
10. Hatun Ş. Çocukluk çağında diyabet. T Klin J
Endocrin 2003; 1:185-197.
11. American Diabetes Association, Nutrition
Recommendations and Interventions for Diabetes.
Diabetes Care January 2008; 31(1):61-78.
12. American Diabetes Association; Management of
Hyperglycemia in Type2 Diabetes: A Patient-
Centered Approach, Diabetes Care Publish Ahead
of Print, published online April 19, 2012.
13. Dan L. Lango, Anthony S. Fauci, Dennis L. Kasper,
et al; Harrison’s Priciples of Internal Medicine,
18th edition, 2012; 2968-3003.
14. Yılmaz C. Vakalarla diyabet 2008, 3. Baskı, Mart
Matbaacılık, 2008.
İletişim:
Uzm.Dr. Vatan Barışık
Özel Metropol Tıp Merkezi, İzmir
tel: +90.505.6406333
e-mail: dr.vatan@hotmail.com

Thank you for copying data from http://www.arastirmax.com